IP Library Granted Patent US 6,869,612
Granted Patent B2
US 6,869,612 · App. 10/210,528 · Granted Mar 22, 2005

Process for preparing purified shilajit composition from native shilajit

Assignees: Natreon, Inc.; Indian Herbs Research & Supply Company Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,869,612
App. No.
10/210,528
Granted
Mar 22, 2005
Kind
B2
Abstract

A purified shilajit composition is provided herein from native shilajit. The composition has an abundance of bioactive components, particularly, at least 0.3%, preferably 0.4-1%, by weight, oxygenated dibenzo-α-pyrones and at least 60%, preferably 65-70%, by weight of fulvic acids of low-to-medium molecular weight ({overscore (M)}n of 700-2000) with an E 4 /E 6 ratio of 8-10 at λ465-665 nm, and whose 2% aqueous solution has a pH of ≧7. Personal care, pharmaceutical and nutritional use formulations of the purified shilajit composition also are described.

Claims (18)

1. A purified shilajit composition comprising:

(a) at least 0.3% by weight of bioactive oxygenated dibenzo-α-pyrones (DBPs), or their esters; present as monomer, dimer and/or tetramers, including free and metal-ion conjugate forms thereof, and

(b) fulvic acids of low-to-medium molecular weight, Mn 700-2000, having an E 4 /E 6 absorption ratio of 8 to 10 at λ465/665 nm which ensure the bioavailability of DBPs by acting as an efficient carrier for the DBPs.

2. A composition according to claim 1 further including about 0.1 to 0.4% of ω-polyunsaturated fatty acids; 0.1-0.4 of a mono- or di-hydroxyacetophenone, or C 16 -C 22 acid esters thereof, and 0.05 to 0.3% of α-lipoic acid.

3. A composition according to claim 1 further including about 3-12% of benzoic acid, or m-hydroxy benzoic acid, or C 16 -C 22 alcohol esters thereof, and about 0.5-1% of —N and —S heterocyclic and other aromatic compounds.

4. A composition according to claim 1 wherein:

(a) is a methanol soluble 3-OH or 3, 8 (OH) 2 DBP derivative, or a C 16 -C 22 ester thereof; and

(b) is a water soluble fulvic acid.

5. A composition according to claim 1 whose 2% aqueous solution has a pH of >7.

6. A composition according to claim 1 wherein

(a) is present in an amount of about 0.4 to 1%, and

(b) is present in an amount of about at least 60%.

7. A personal care, pharmaceutical or nutritional formulation comprising the composition of claim 1 present therein in an amount of about 0.1 to 60% by weight.

8. A skin care or protection formulation according to claim 7 in the form of a lotion, cream or gel, wherein said composition is present in an amount of about 0.1-5%.

9. A pharmaceutical formulation according to claim 7 in the form of a tablet, syrup, elixir or capsule.

10. A nutritional formulation according to claim 7 which contains about 0.5 to 30% of said composition.

11. A skin care or protection formulation according to claim 7 which additionally contains a cosmetically acceptable carrier and at least one cosmetic adjuvant selected from the group of sunscreens, antioxidants, preservatives, perfumes, oils, waxes, propellants, waterproofing agents, emulsifiers, thickeners, humectants and emollients.

12. A composition according to claim 1 in which humic acid, humins and polymeric quinones are substantially absent therein.

Continuity (2)
Division 0986089000 · May 18, 2001
Related Publication 20030039662A1 · Feb 27, 2003